Phenotype and genotype of thiopurine methyltransferase in Chilean individuals
dc.contributor.author | Jorquera, Andres | |
dc.contributor.author | Solari, Sandra | |
dc.contributor.author | Vollrath, Valeska | |
dc.contributor.author | Guerra, Irene | |
dc.contributor.author | Chianale, Jose | |
dc.contributor.author | Cofre, Colomba | |
dc.contributor.author | Kalergis, Alexis | |
dc.contributor.author | Ibanez, Patricio | |
dc.contributor.author | Bueno, Susan | |
dc.contributor.author | Alvarez Lobos, Manuel | |
dc.date.accessioned | 2024-01-10T13:16:13Z | |
dc.date.available | 2024-01-10T13:16:13Z | |
dc.date.issued | 2012 | |
dc.description.abstract | Background: Thiopurines (azathioprine and 6-mercaptopurine) are highly effective medications but with potential adverse effects. Thiopurine methyltransferase (TMPT) is the key enzyme in their pharmacokinetics and is genetically regulated. A low activity of TPMT is associated with myelotoxicity. The genotype and enzyme activity can vary by ethnicity. Aim: To study the activity and genotype of TPMT in a group of Chilean subjects. Material and Methods: In 200 healthy adult blood donors, TPMT activity was determined by high performance liquid chromatography (HPLC). Deficient, low, normal or high levels were defined when enzymatic activity was <= 5, 6-24, 25-55 and >= 56 nmol/grHb/h, respectively. Genotyping of TPMT ((star)1, (star)2, (star)3A, (star)3B, (star)3C) was performed by PCR. Results: Seventy seven women (38.5%) and 123 men (61.5%), with an average age of 34.9 years were studied. Eighteen subjects (9%) had a low enzymatic activity, 178 (89%) had normal activity, 4 (2%) had high activity and no genotype deficient subjects were identified. The wild type genotype ((star)1) was found in 184 (92%) individuals and 16 (8%) were heterozygous for the variants: (star)2 (n = 2), (star)3A (n = 13) and (star)3C (n = 1). No homozygous subjects for these variants were identified. Wild type genotype had an increased enzymatic activity (40.8 +/- 7.2 nmol/gHb/h) compared to heterozygous group (21.2 +/- 3 nmol/gHb/h; p < 0.001). Conclusions: Less than 10% of a Chilean population sample has a low enzymatic activity or allelic variants in the TPMT gene, supporting the use of thiopurines according to international recommendations. (Rev Med Chile 2012; 140: 889-895). | |
dc.fechaingreso.objetodigital | 2024-05-28 | |
dc.format.extent | 7 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.4067/S0034-98872012000700009 | |
dc.identifier.eissn | 0717-6163 | |
dc.identifier.issn | 0034-9887 | |
dc.identifier.pubmedid | MEDLINE:23282701 | |
dc.identifier.uri | https://doi.org/10.4067/S0034-98872012000700009 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/78568 | |
dc.identifier.wosid | WOS:000308280100009 | |
dc.information.autoruc | Medicina;Alvarez M ;S/I;6131 | |
dc.information.autoruc | Ciencias Biológicas;Bueno S ;S/I;113541 | |
dc.information.autoruc | Medicina;Chianale J;S/I;99780 | |
dc.information.autoruc | Medicina;Cofre C;S/I;87671 | |
dc.information.autoruc | Medicina;Guerra I ;S/I;117495 | |
dc.information.autoruc | Medicina;Ibanez P ;S/I;135641 | |
dc.information.autoruc | Medicina;Jorquera A ;S/I;152756 | |
dc.information.autoruc | Ciencias Biológicas;Kalergis A ;S/I;90610 | |
dc.information.autoruc | Medicina;Solari S ;S/I;1871 | |
dc.information.autoruc | Ciencias Biológicas;Vollrath V;S/I;2185 | |
dc.issue.numero | 7 | |
dc.language.iso | es | |
dc.nota.acceso | Contenido completo | |
dc.pagina.final | 895 | |
dc.pagina.inicio | 889 | |
dc.publisher | SOC MEDICA SANTIAGO | |
dc.revista | REVISTA MEDICA DE CHILE | |
dc.rights | acceso abierto | |
dc.subject | Drug hypersensitivity | |
dc.subject | Chile | |
dc.subject | Gentype | |
dc.subject | TPMT deficiency | |
dc.subject | Phenotype | |
dc.subject | INFLAMMATORY-BOWEL-DISEASE | |
dc.subject | S-METHYLTRANSFERASE | |
dc.subject | AZATHIOPRINE | |
dc.subject | PHARMACOGENETICS | |
dc.subject | 6-MERCAPTOPURINE | |
dc.subject | 6-THIOGUANINE | |
dc.subject | INHERITANCE | |
dc.subject | MANAGEMENT | |
dc.subject | DEFICIENCY | |
dc.subject | SUBSTRATE | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Phenotype and genotype of thiopurine methyltransferase in Chilean individuals | |
dc.type | artículo | |
dc.volumen | 140 | |
sipa.codpersvinculados | 6131 | |
sipa.codpersvinculados | 113541 | |
sipa.codpersvinculados | 99780 | |
sipa.codpersvinculados | 87671 | |
sipa.codpersvinculados | 117495 | |
sipa.codpersvinculados | 135641 | |
sipa.codpersvinculados | 152756 | |
sipa.codpersvinculados | 90610 | |
sipa.codpersvinculados | 1871 | |
sipa.codpersvinculados | 2185 | |
sipa.index | WOS | |
sipa.index | Scopus | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Phenotype and genotype of thiopurine methyltransferase in Chilean individuals.pdf
- Size:
- 143.59 KB
- Format:
- Adobe Portable Document Format
- Description: